Bicyclol Tablets | China Drugs List
Public reference information, not medical advice, a prescription or an offer to supply a medicine. Confirm current approval, availability and suitability with licensed professionals.
- Brand
- Baisainuo
- Company
- Beijing Union Pharmaceutical Factory; developed by the Institute of Materia Medica, Chinese Academy of Medical Sciences.
- Medicine type
- Chemical medicine
- Therapeutic area
- Gastroenterology
- Indications recorded in the public source
- For elevated aminotransferase levels caused by chronic hepatitis.
- Indication source and scope
- The revision date could not be confirmed from the original file.
- Prescribing-information limitations
- A verifiable complete prescribing-information document has not yet been obtained. Available approval records or NHSA submissions support the indications shown; the latest full scope needs confirmation.
- China availability status
- Historical Chinese approval verified; current continuous market availability has not been checked for every product.
- Overseas status
- Market-by-market verification pending.
- Insurance classification
- Included in national insurance (Category B)
- Insurance edition
- 2025 edition; effective 1 January 2026
- Insurance restrictions
- No additional restriction is specified for this list entry; the list's general rules and approved indications still apply.
- Insurance verification notes
- Matched by exact or normalized ingredient/formulation name. Reimbursement still depends on the dosage form and listed payment restrictions.
Sources
- https://www.imm.ac.cn/xycz/sscxyw/cf80e24a47a04ab5bd3ed306687e91fb.htm
- https://www.nhsa.gov.cn/module/download/downfile.jsp?classid=0&filename=a32f9f2f3fc046afaf08471f87456ce3.pdf
- https://www.baisainuo.com/product/7.html
Open the interactive record, public price references and discussions